Found: 116
Select item for more details and to access through your institution.
Cabergoline targets multiple pathways to inhibit PRL secretion and increases stromal fibrosis.
- Published in:
- European Journal of Endocrinology, 2024, v. 190, n. 6, p. 467, doi. 10.1093/ejendo/lvae055
- By:
- Publication type:
- Article
Effects of cabergoline and dimethylcabergoline on the sexual behavior of male rats.
- Published in:
- Psychopharmacology, 2024, v. 241, n. 4, p. 717, doi. 10.1007/s00213-023-06501-9
- By:
- Publication type:
- Article
P-53 Resistant macroprolactinoma.
- Published in:
- JCEM Case Reports, 2024, v. 2, p. 1, doi. 10.1210/jcemcr/luad146.055
- By:
- Publication type:
- Article
Efficacy of cabergoline in non-irradiated patients with acromegaly: a multi-centre cohort study.
- Published in:
- European Journal of Endocrinology, 2024, v. 190, n. 1, p. 113, doi. 10.1093/ejendo/lvae003
- By:
- Publication type:
- Article
Pasireotide: potential treatment option for McCune–Albright-associated acromegaly.
- Published in:
- European Journal of Endocrinology, 2024, v. 190, n. 1, p. K17, doi. 10.1093/ejendo/lvad173
- By:
- Publication type:
- Article
Simultaneously administration of cabergoline and PMSG reduces the duration of estrus induction in anestrous bitches.
- Published in:
- Veterinary Research Forum, 2023, v. 14, n. 12, p. 665, doi. 10.30466/vrf.2023.1999602.3843
- By:
- Publication type:
- Article
Effects of combined metformin and cabergoline versus metformin alone on ovarian and hormonal activities in Iraqi patients with PCOS and hyperprolactinemia: a randomized clinical trial.
- Published in:
- Journal of Medicine & Life, 2023, v. 16, n. 11, p. 1615, doi. 10.25122/jml-2023-0317
- By:
- Publication type:
- Article
Long-term efficacy and safety of subcutaneous pasireotide alone or in combination with cabergoline in Cushing's disease.
- Published in:
- Frontiers in Endocrinology, 2023, p. 1, doi. 10.3389/fendo.2023.1165681
- By:
- Publication type:
- Article
Cabergoline and Low-Dose Steroid Therapy İn Idiopathic Granulomatous Mastitis.
- Published in:
- Dicle Medical Journal / Dicle Tip Dergisi, 2023, v. 50, n. 3, p. 287, doi. 10.5798/dicletip.1360588
- By:
- Publication type:
- Article
PROLACTINOMA - THE MOST COMMON PITUITARY TUMOR. A LITERATURE REVIEW.
- Published in:
- Polish Journal of Applied Sciences, 2023, v. 9, n. 3, p. 20, doi. 10.19260/PJAS.2023.9.3.03
- By:
- Publication type:
- Article
Improving pregnancy rate in infertile patients with polycystic ovarian syndrome receiving clomiphene citrate and cabergoline in euprolactinomic women in single cycle treatment.
- Published in:
- Ginekologia Polska, 2023, v. 94, n. 6, p. 456, doi. 10.5603/GP.a2022.0070
- By:
- Publication type:
- Article
Cardiometabolic Effects of Cabergoline and Combined Oral Contraceptive Pills in Young Women with Hyperprolactinemia: A Pilot Study.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 9, p. 3208, doi. 10.3390/jcm12093208
- By:
- Publication type:
- Article
Macroprolactinoma with secondary resistance to dopamine agonists: a case report and review of the literature.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Impulse Control Disorders with Short-term Use of Cabergoline in Macroprolactinomas: A Prospective Study with a Brief Review of Literature.
- Published in:
- Neurology India, 2023, v. 71, n. 1, p. 107, doi. 10.4103/0028-3886.370452
- By:
- Publication type:
- Article
Cabergoline Failure and a Spontaneous Pregnancy in a Microprolactinoma with High Prolactin Levels.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Effect of cabergoline on tumor remnant after surgery in nonfunctioning pituitary adenoma.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 160, n. 2, p. 351, doi. 10.1007/s11060-022-04149-7
- By:
- Publication type:
- Article
Cabergoline: an effective treatment for conception in prolactinoma.
- Published in:
- Biomedica, 2022, v. 38, n. 3, p. 163, doi. 10.51441/BioMedica/5-750
- By:
- Publication type:
- Article
A validated LC–MS/MS method for analysis of Cabergoline in human plasma with its implementation in a bioequivalent study: investigation of method greenness.
- Published in:
- BMC Chemistry, 2022, v. 16, n. 1, p. 1, doi. 10.1186/s13065-022-00862-6
- By:
- Publication type:
- Article
Hyperprolactinemia in children and adolescents and long-term follow-up results of prolactinoma cases: a single-centre experience.
- Published in:
- Turkish Journal of Pediatrics, 2022, v. 64, n. 5, p. 892, doi. 10.24953/turkjped.2021.4639
- By:
- Publication type:
- Article
Hydroxychloroquine overcomes cabergoline resistance in a patient with Lactotroph Pituitary neuroendocrine tumor: a case report.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.955100
- By:
- Publication type:
- Article
Outcome of Dopamine Agonist Therapy Withdrawal in Children with Prolactinomas.
- Published in:
- Hormone Research in Paediatrics, 2022, v. 95, n. 3, p. 291, doi. 10.1159/000525226
- By:
- Publication type:
- Article
Treatment of Prolactinoma.
- Published in:
- Medicina (1010660X), 2022, v. 58, n. 8, p. 1095, doi. 10.3390/medicina58081095
- By:
- Publication type:
- Article
DRD2 Agonist Cabergoline Abolished the Escape Mechanism Induced by mTOR Inhibitor Everolimus in Tumoral Pituitary Cells.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.867822
- By:
- Publication type:
- Article
Binge Eating and Compulsive Buying During Cabergoline Treatment for Prolactinoma: A Case Report.
- Published in:
- Frontiers in Psychiatry, 2022, v. 13, p. 1, doi. 10.3389/fpsyt.2022.844718
- By:
- Publication type:
- Article
Case report: Bilateral simple Syndactyly in a toddler with maternal exposure to cabergoline.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Effect of the Prolactin Inhibitor Cabergoline and the Gonadotropin Releasing-Hormone Agonist Deslorelin in the Suppression of Plasma Prolactin Concentrations and Egg Laying in Quail (Coturnix japonica).
- Published in:
- Journal of Avian Medicine & Surgery, 2022, v. 36, n. 1, p. 39, doi. 10.1647/20-00075
- By:
- Publication type:
- Article
Cabergoline Stimulates Human Endometrial Stromal Cell Decidualization and Reverses Effects of Interleukin-1β In Vitro.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Effects of Pituitary Surgery and High-Dose Cabergoline Therapy on Metabolic Profile in Patients With Prolactinoma Resistant to Conventional Cabergoline Treatment.
- Published in:
- Frontiers in Endocrinology, 2021, v. 12, p. 1, doi. 10.3389/fendo.2021.769744
- By:
- Publication type:
- Article
Cabergoline in Treatment of Methamphetamine-Dependent Patients and Its Effect on Serum Level of Glial Cell-Derived Neurotrophic Factor: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
- Published in:
- European Addiction Research, 2021, v. 27, n. 6, p. 457, doi. 10.1159/000515398
- By:
- Publication type:
- Article
A scoping review to understand the indications, effectiveness, and limitations of cabergoline in radiological and biochemical remission of prolactinomas.
- Published in:
- Indian Journal of Endocrinology & Metabolism, 2021, v. 25, n. 6, p. 493, doi. 10.4103/ijem.ijem_338_21
- By:
- Publication type:
- Article
Long‐term response to cabergoline and multi‐modal treatment in men with macroprolactinoma: Does size really matter?
- Published in:
- Clinical Endocrinology, 2021, v. 95, n. 4, p. 606, doi. 10.1111/cen.14541
- By:
- Publication type:
- Article
Shrinkage by the third month predicts long-term response of macroprolactinoma after cabergoline.
- Published in:
- European Journal of Endocrinology, 2021, v. 185, n. 4, p. 587, doi. 10.1530/EJE-21-0561
- By:
- Publication type:
- Article
Cabergoline should be attempted in progressing non-functioning pituitary macroadenoma.
- Published in:
- European Journal of Endocrinology, 2021, v. 185, n. 4, p. D11, doi. 10.1530/EJE-21-0344
- By:
- Publication type:
- Article
High Dose Cabergoline in Management of Bilateral Ovarian Hyperstimulation Syndrome: A Case Report.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Evaluation of cabergoline for lactation inhibition in women living with HIV.
- Published in:
- International Journal of STD & AIDS, 2021, v. 32, n. 7, p. 654, doi. 10.1177/0956462420984694
- By:
- Publication type:
- Article
In Vivo and In Vitro Study of the Genetic Effects of Cabergoline Drug.
- Published in:
- Iraqi Journal of Science, 2021, v. 62, n. 5, p. 1477, doi. 10.24996/ijs.2021.62.5.11
- By:
- Publication type:
- Article
Oxytocin and cabergoline alleviate ovarian hyperstimulation syndrome (OHSS) by suppressing vascular endothelial growth factor (VEGF) in an experimental model.
- Published in:
- Archives of Gynecology & Obstetrics, 2021, v. 303, n. 4, p. 1099, doi. 10.1007/s00404-020-05855-1
- By:
- Publication type:
- Article
Raynaud's phenomenon caused by cabergoline during the treatment of a macroprolactinoma: a case report.
- Published in:
- Revista Latinoamericana de Hipertension, 2021, v. 16, n. 2, p. 176, doi. 10.5281/zenodo.5514223
- By:
- Publication type:
- Article
Biochemical Remission after Cabergoline Withdrawal in Hyperprolactinemic Patients with Visible Remnant Pituitary Adenoma.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2021, v. 106, n. 2, p. e616, doi. 10.1210/clinem/dgaa744
- By:
- Publication type:
- Article
Predictors of Chronic LH-Testosterone Axis Suppression in Male Macroprolactinomas With Normoprolactinemia on Cabergoline.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Termination of Pregnancy in Mismated Bitches using Cloprostenol and Cabergoline.
- Published in:
- Indian Journal of Veterinary Sciences & Biotechnology, 2020, v. 16, n. 2/4, p. 89, doi. 10.21887/ijvsbt.16.(2,3,&4).20
- By:
- Publication type:
- Article
A Combination of Exercise and Therapy with Cabergoline Attenuate Disturbances of Pituitary-Gonadal Hormones in Hyperprolactinemic Male Patients.
- Published in:
- Montenegrin Journal of Sports Science & Medicine, 2020, v. 9, n. 2, p. 35, doi. 10.26773/mjssm.200906
- By:
- Publication type:
- Article
Experimental Studies of the Effects of the Dopamine D<sub>2</sub> Receptor Agonist Cabergoline on Catecholamine Content and BDNF mRNA Expression in the Midbrain and Hypothalamus.
- Published in:
- Neuroscience & Behavioral Physiology, 2020, v. 50, n. 7, p. 830, doi. 10.1007/s11055-020-00974-3
- By:
- Publication type:
- Article
Conscious perception and the modulatory role of dopamine: no effect of the dopamine D2 agonist cabergoline on visual masking, the attentional blink, and probabilistic discrimination.
- Published in:
- Psychopharmacology, 2020, v. 237, n. 9, p. 2855, doi. 10.1007/s00213-020-05579-9
- By:
- Publication type:
- Article
Effects of Infertility by Cabergoline on Serum Sex Hormones and the Inter- and Intra-Sexual Social Behaviors of Female Rattus losea.
- Published in:
- Pakistan Journal of Zoology, 2020, v. 52, n. 4, p. 1309, doi. 10.17582/journal.pjz/20190110070138
- By:
- Publication type:
- Article
Cabergoline: the paliperidone "antidote".
- Published in:
- European Psychiatry, 2020, v. 63, p. S212
- By:
- Publication type:
- Article
EFFECT OF MIFEPRISTONE AND CABERGOLINE IN THE TERMINATION OF PREGNANCY IN BITCHES.
- Published in:
- Indian Journal of Animal Reproduction, 2020, v. 41, n. 1, p. 56
- By:
- Publication type:
- Article
Dopamine Modulates Dynamic Decision-Making during Foraging.
- Published in:
- Journal of Neuroscience, 2020, v. 40, n. 27, p. 5273, doi. 10.1523/jneurosci.2586-19.2020
- By:
- Publication type:
- Article
Treatment of Pituitary and Other Tumours with Cabergoline: New Mechanisms and Potential Broader Applications.
- Published in:
- Neuroendocrinology, 2020, v. 110, n. 6, p. 477, doi. 10.1159/000504000
- By:
- Publication type:
- Article
The Efficacy of Using Cabergoline in Psychogenic Erectile Dysfunction Treatment (A Local Study).
- Published in:
- Systematic Reviews in Pharmacy, 2020, v. 11, n. 3, p. 702, doi. 10.31838/srp.2020.3.95
- By:
- Publication type:
- Article